Akebia Therapeutics (AKBA) Gross Profit (QoQ) (2019 - 2026)
Akebia Therapeutics (AKBA) Gross Profit (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.32 Bn | 18.52 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Akebia Therapeutics | 341.82 Mn | 179.22 Mn | 41.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.50% |
| Dec 31, 2025 | -8.70% |
| Sep 30, 2025 | -6.03% |
| Jun 30, 2025 | 5.72% |
| Mar 31, 2025 | 41.46% |
| Dec 31, 2024 | 8.87% |
| Sep 30, 2024 | 21.34% |
| Jun 30, 2024 | 26.66% |
| Mar 31, 2024 | -54.87% |
| Dec 31, 2023 | 93.62% |
| Sep 30, 2023 | -38.51% |
| Jun 30, 2023 | 35.61% |
| Mar 31, 2023 | -10.42% |
| Dec 31, 2022 | 208.43% |
| Sep 30, 2022 | -90.32% |
| Jun 30, 2022 | 567.95% |
| Mar 31, 2022 | 85.93% |
| Dec 31, 2021 | -491.31% |
| Sep 30, 2021 | 343.56% |
| Jun 30, 2021 | -64.70% |